Compound Summary
OXCARBAZEPINE
Compound Information
OXCARBAZEPINE
Compound Name: | OXCARBAZEPINE |
Compound CID: | 34312 |
Synonyms: | OXCARBAZEPINE 28721-07-5 Trileptal Oxcarbamazepine Oxcarbazepina More... |
Iupac Name: | 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide |
InChI: | InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19) |
InChIKey: | CTRLABGOLIVAIY-UHFFFAOYSA-N |
Canonical Smiles: | C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N |
Isomeric Smiles: | C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N |
Molecular Weight: | 252.27 |
Molecular Formula: | C15H12N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
OXCARBAZEPINE
Molecular Weight: | 252.27 |
Molecular Formula: | C15H12N2O2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 19 |
Complexity: | 382 |
Synonyms
OXCARBAZEPINE
| OXCARBAZEPINE | OXCARBAZEPINE |
|---|---|
OXCARBAZEPINE |
28721-07-5 |
Trileptal |
Oxcarbamazepine |
Oxcarbazepina |
Oxcarbazepinum |
GP 47680 |
10-Oxo-10,11-dihydro-5H-dibenzob,fazepine-5-carboxamide |
5-oxo-6H-benzob1benzazepine-11-carboxamide |
KIN-493 |
GP-47680 |
10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide |
10,11-Dihydro-10-oxo-5H-dibenzb,fazepine-5-carboxamide |
UNII-VZI5B1W380 |
5H-Dibenzb,fazepine-5-carboxamide, 10,11-dihydro-10-oxo- |
MLS000084586 |
SPN-804 |
9-oxo-2-azatricyclo9.4.0.0^{3,8}pentadeca-1(11),3(8),4,6,12,14-hexaene-2-carboxamide |
5H-Dibenz(b,f)azepine-5-carboxamide, 10,11-dihydro-10-oxo- |
CHEMBL1068 |
SMR000048684 |
CHEBI:7824 |
VZI5B1W380 |
Oxacarbazepine |
Timox |
MFCD00865307 |
NCGC00065934-02 |
DSSTox_CID_25703 |
DSSTox_RID_81075 |
DSSTox_GSID_45703 |
Oxcarbazepinum INN-Latin |
Oxcarbazepina INN-Spanish |
Oxcarbazepime |
Epilexter |
Epliga |
Oxtellar XR |
Trileptal (TN) |
CAS-28721-07-5 |
SR-01000612612 |
EINECS 249-188-8 |
Oxcarbazepin |
Oxcarbazepine-d4 |
HSDB 7524 |
Oxtellar (TN) |
Oxcarbazepine USAN:USP:INN:BAN |
OCBZ |
Oxcarbazepine solution |
Oxcarbazepine- Bio-X |
Spectrum_001675 |
Opera_ID_818 |
regid866068 |
Spectrum2_000483 |
Spectrum3_001669 |
Spectrum4_000634 |
Spectrum5_001869 |
O0363 |
SCHEMBL35129 |
BSPBio_003457 |
KBioGR_001248 |
KBioSS_002155 |
cid_34312 |
MLS000759520 |
MLS001201742 |
MLS001424025 |
MLS006011855 |
BIDD:GT0078 |
SPECTRUM1504243 |
SPBio_000345 |
GTPL7254 |
Oxcarbazepine (JAN/USP/INN) |
ZINC4724 |
DTXSID0045703 |
BDBM34179 |
KBio2_002155 |
KBio2_004723 |
KBio2_007291 |
KBio3_002677 |
Oxcarbazepine, analytical standard |
10,11-Dihydro-10-oxo-5H-dibenzob,fazepine-5-carboxamide |
HMS1922H17 |
HMS2051O04 |
HMS2090F13 |
HMS2093E10 |
HMS2231B12 |
HMS3369J22 |
HMS3393O04 |
HMS3657O11 |
HMS3713I10 |
HMS3884K13 |
Pharmakon1600-01504243 |
BCP28260 |
BCP33398 |
HY-B0114 |
Tox21_110983 |
BBL010789 |
CCG-39509 |
NSC758693 |
s1391 |
STK594696 |
AKOS005516529 |
Tox21_110983_1 |
AC-3483 |
CS-1869 |
DB00776 |
KS-5197 |
MCULE-9100100302 |
NC00088 |
NSC 758693 |
NSC-758693 |
Oxcarbazepine, >=98% (HPLC), solid |
NCGC00065934-03 |
NCGC00065934-04 |
NCGC00065934-05 |
NCGC00065934-06 |
BO164187 |
SBI-0206772.P001 |
AB0012847 |
GP-47-680 |
AM20040094 |
FT-0630543 |
FT-0673414 |
SW197468-3 |
A13943 |
C07492 |
D00533 |
J10384 |
M06310 |
AB00393017-12 |
AB00393017-14 |
AB00393017_15 |
AB00393017_16 |
721O075 |
Q176301 |
SR-01000612612-4 |
SR-01000612612-6 |
W-107033 |
BRD-K04196797-001-12-9 |
10-oxo-10,11-dihydro-5H-dibenz(b,f)azepin-5-carboxamide |
5-carbamoyl-10-oxo-10,11-dihydro-5H-dibenzb,fazepine |
10,11-Dihydro-10-oxo-5H-dibenzb,fazepin-5-carbonsaeureamid |
10-Oxo-10,11-dihydro-5H-dibenzob,fazepine-5-carboxamide # |
Oxcarbazepine, European Pharmacopoeia (EP) Reference Standard |
10,11-Dihydro-10-oxo-5H-dibenzo(Z)b,fazepine-5-carboxamide |
Oxcarbazepine, United States Pharmacopeia (USP) Reference Standard |
10-Oxo carbazepine; Oxecarb; 10,11-Dihdyro-10-oxo-5H-dibenzb,fazepine-5-carboxamide |
Oxcarbazepine, Pharmaceutical Secondary Standard; Certified Reference Material |
Oxcarbazepine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material |
Oxcarbazepine-13C6 solution, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material |
Experimental Data
OXCARBAZEPINE
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drosophila melanogaster | 200.000000000000000 | umol/L | 43.170000000000000 | 44.870000000000000 | 3.940000000000000 | NS | MALES | 33008901 | Inactive | ||||
| Drosophila melanogaster | 20.000000000000000 | umol/L | 44.630000000000000 | 45.900000000000000 | 2.843000000000000 | NS | FEMALES | 33008901 | Inactive | ||||
| Caenorhabditis elegans | 100.000000000000000 | umol/L | 17.250000000000000 | 14.160000000000000 | -17.920000000000000 | NS | N2 | 33008901 | Inactive | ||||
| Caenorhabditis elegans | 10.000000000000000 | umol/L | 16.600000000000000 | 16.220000000000000 | -2.286000000000000 | NS | N2 | 33008901 | Inactive |
Experimental Data Visualization
OXCARBAZEPINE
Statistics Data
OXCARBAZEPINE
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -2.286000000000000 | 1 | 2 | |
| Drosophila melanogaster | 3.940000000000000 | 1 | 2 |
Statistics Data Visualization
OXCARBAZEPINE
